CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...

The Board of Directors of PTC India Limited ("Company") at its meeting held today i.e. 26th April, 2025 have considered and ...